The meeting focused on optimizing the distribution of essential medicines through EPTC's extensive network of pharmacies and branches across the country
Data showed that approximately 918 million units of medication were sold in the first quarter, up from 863 million units during the same period the previous year.
This increase is expected to play a key role in replacing approximately $3 billion worth of annual pharmaceutical imports with locally produced alternatives.
Key points of discussion included the local manufacturing of oncology drugs, as well as the evolving role of biosimilars in the region.
Kuwait-based Ali Alghanim & Sons Group is exploring opportunities for expansion in Egypt, including a potential plan to establish an insulin factory in collaboration with foreign partners.
